Infarct in a New Territory After Treatment Administration in the ESCAPE Randomized Controlled Trial (Endovascular Treatment for Small Core and Anterior Circulation Proximal Occlusion With Emphasis on Minimizing CT to Recanalization Times)
Author(s) -
Aravind Ganesh,
Fahad Al-Ajlan,
Farahna Sabiq,
Zarina Assis,
Jeremy Rempel,
Kenneth Butcher,
John Thornton,
Peter J. Kelly,
Daniel Roy,
Alexandre Y. Poppe,
Tudor Jovin,
Thomas Devlin,
Blaise Baxter,
Timo Krings,
Leanne K. Casaubon,
Donald Frei,
Hana Choe,
Donatella Tampieri,
Jeanne Teitelbaum,
Cheemun Lum,
Jennifer Mandzia,
Stephen Phillips,
Oh Young Bang,
Mohammed Almekhlafi,
Shelagh B. Coutts,
Philip A. Barber,
Tolulope T. Sajobi,
Andrew M. Demchuk,
Muneer Eesa,
Michael D. Hill,
Mayank Goyal,
Bijoy K. Me
Publication year - 2016
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.116.014852
Subject(s) - medicine , odds ratio , confidence interval , randomized controlled trial , occlusion , logistic regression , modified rankin scale , ostium , surgery , radiology , ischemia , ischemic stroke
Infarct in a new previously unaffected territory (INT) is a potential complication of endovascular treatment. We applied a recently proposed methodology to identify and classify INTs in the ESCAPE randomized controlled trial (Endovascular Treatment for Small Core and Anterior Circulation Proximal Occlusion With Emphasis on Minimizing CT to Recanalization Times).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom